Abstract
Background/Objectives
Apolipoprotein (ApoE ε4) status has been associated with various cardiovascular diseases and Alzheimer’s Disease. Some studies have found a possible relationship between the presence of an ApoE ε4 allele and the decrease of motor function in healthy older adults. The objective of this study was to measure the cross-sectional and prospective associations of ApoE ε4 status with lower limb function and handgrip strength in older adults.
Design
Longitudinal observational study using data from a randomized controlled trial.
Setting
Community-dwelling older adults.
Participants
1300 older adults (≥70 years old) with ApoE ε4 status from the Multidomain Alzheimer’s Preventive Trial (MAPT) were followed for three years.
Measurements
Lower-limb function was measured with the Short Physical Performance Battery (SPPB) and muscle strength was measured with a handgrip strength dynamometer. ApoE ε4 status was assessed with a blood draw. Mixed-effect linear regressions were used to examine cross-sectional as well as prospective associations between ApoE ε4 status and the outcomes.
Results
No significant cross-sectional or prospective associations were found between ApoE ε4 status, lower-limb function and handgrip strength in our study.
Conclusions
ApoE ε4 status was not associated with motor function in older adults.
Similar content being viewed by others
References
Marsh AP, Rejeski WJ, Espeland MA, et al. Muscle strength and BMI as predictors of major mobility disability in the Lifestyle Interventions and Independence for Elders pilot (LIFE-P). J Gerontol A Biol Sci Med Sci. 2011 Dec;66(12):1376–83. doi: https://doi.org/10.1093/gerona/glr158. PubMed PMID: 21975090; PubMed Central PMCID: PMCPMC3210962. eng.
Bergland A, Jorgensen L, Emaus N, et al. Mobility as a predictor of all-cause mortality in older men and women: 11.8 year follow-up in the Tromso study. BMC health services research. 2017 Jan 10;17(1):22. doi: https://doi.org/10.1186/s12913-016-1950-0. PubMed PMID: 28068995; PubMed Central PMCID: PMCPMC5223479. eng.
Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci. 2012 Jan;67(1):28–40. doi: https://doi.org/10.1093/gerona/glr010. PubMed PMID: 21444359; PubMed Central PMCID: PMCPMC3260480. eng.
Lexell J. Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci. 1995 Nov;50 Spec No:11–6. PubMed PMID: 7493202; eng.
Nilwik R, Snijders T, Leenders M, et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Experimental Gerontology. 2013 2013/05/01/;48(5):492–498. doi: https://doi.org/10.1016/j.exger.2013.02.012.
McPhee JS, Cameron J, Maden-Wilkinson T, et al. The contributions of fibre atrophy, fibre loss, in situ specific force and voluntary activation to weakness in sarcopenia. Journals of Gerontology, Series A. 2018.
Aagaard P, Suetta C, Caserotti P, et al. Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure. Scandinavian Journal of Medicine & Science in Sports. 2010;20(1):49–64. doi: https://doi.org/10.1111/j.1600-0838.2009.01084.x.
Sheth KA, Iyer CC, Wier CG, et al. Muscle strength and size are associated with motor unit connectivity in aged mice. Neurobiology of aging. 2018 Jul;67:128–136. doi: https://doi.org/10.1016/j.neurobiolaging.2018.03.016. PubMed PMID: 29656012; PubMed Central PMCID: PMCPMC5981861. eng.
Mau-Moeller A, Behrens M, Lindner T, et al. Age-related changes in neuromuscular function of the quadriceps muscle in physically active adults. Journal of electromyography and kinesiology: official journal of the International Society of Electrophysiological Kinesiology. 2013 Jun;23(3):640–8. doi: https://doi.org/10.1016/j.jelekin.2013.01.009. PubMed PMID: 23453325; eng.
Cesari M, Fielding RA, Pahor M, et al. Biomarkers of sarcopenia in clinical trials—recommendations from the International Working Group on Sarcopenia. Journal of Cachexia, Sarcopenia and Muscle. 2012;3(3):181–190. doi: https://doi.org/10.1007/s13539-012-0078-2.
Mahley RW. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. Journal of molecular medicine (Berlin, Germany). 2016 Jul;94(7):739–46. doi: https://doi.org/10.1007/s00109-016-1427-y. PubMed PMID: 27277824; PubMed Central PMCID: PMCPMC4921111. eng.
Liu Y, Yu JT, Wang HF, et al. APOE genotype and neuroimaging markers of Alzheimer’s disease: systematic review and meta-analysis. Journal of neurology, neurosurgery, and psychiatry. 2015 Feb;86(2):127–34. doi: https://doi.org/10.1136/jnnp-2014-307719. PubMed PMID: 24838911; PubMed Central PMCID: PMCPMC4331076. eng.
Buchman AS, Boyle PA, Wilson RS, et al. Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons. Alzheimer Dis Assoc Disord. 2009 Jan–Mar;23(1):63–9. PubMed PMID: 19266700; PubMed Central PMCID: PMCPMC2662708.
Albert SM, Gurland B, Maestre G, et al. APOE genotype influences functional status among elderly without dementia. American journal of medical genetics. 1995 Dec 18;60(6):583–7. doi: https://doi.org/10.1002/ajmg.1320600621. PubMed PMID: 8825902; eng.
Blazer DG, Fillenbaum G, Burchett B. The APOE-E4 allele and the risk of functional decline in a community sample of African American and white older adults. J Gerontol A Biol Sci Med Sci. 2001 Dec;56(12):M785–9. PubMed PMID: 11723155; eng.
Melzer D, Dik MG, van Kamp GJ, et al. The apolipoprotein E e4 polymorphism is strongly associated with poor mobility performance test results but not self-reported limitation in older people. J Gerontol A Biol Sci Med Sci. 2005 Oct;60(10):1319–23. PubMed PMID: 16282567; PubMed Central PMCID: PMCPMC1892815. eng.
Carmelli D, DeCarli C, Swan GE, et al. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. J Gerontol A Biol Sci Med Sci. 2000 Feb;55(2):M103–9. PubMed PMID: 10737693; eng.
Verghese J, Holtzer R, Wang C, et al. Role of APOE genotype in gait decline and disability in aging. J Gerontol A Biol Sci Med Sci. 2013 Nov;68(11):1395–401. doi: https://doi.org/10.1093/gerona/glt115. PubMed PMID: 23902934; PubMed Central PMCID: PMCPMC3805293.
Guralnik JM, Ferrucci L, Pieper CF, et al. Lower Extremity Function and Subsequent Disability: Consistency Across Studies, Predictive Models, and Value of Gait Speed Alone Compared With the Short Physical Performance Battery. The Journals of Gerontology: Series A. 2000;55(4):M221–M231. doi: https://doi.org/10.1093/gerona/55.4.M221.
Vellas B, Carrie I, Gillette-Guyonnet S, et al. MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER’S DISEASE: DESIGN AND BASELINE DATA. J Prev Alzheimers Dis. 2014 Jun;1(1):13–22. PubMed PMID: 26594639; PubMed Central PMCID: PMCPMC4652787. eng.
Andrieu S, Guyonnet S, Coley N, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. The Lancet Neurology. 2017;16(5):377–389.
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. Journal of gerontology. 1994 Mar;49(2):M85–94. PubMed PMID: 8126356; eng.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–98. PubMed PMID: 1202204; eng.
Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. Journal of psychiatric research. 1982;17(1):37–49.
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146–56. PubMed PMID: 11253156; eng.
Partridge L, Deelen J, Slagboom PE. Facing up to the global challenges of ageing. Nature. 2018 2018/09/01;561(7721):45–56. doi: https://doi.org/10.1038/s41586-018-0457-8.
Moon SY, de Souto Barreto P, Rolland Y, et al. Prospective associations between white matter hyperintensities and lower extremity function. Neurology. 2018 Apr 10;90(15):e1291–e1297. doi: https://doi.org/10.1212/wnl.0000000000005289. PubMed PMID: 29523640; eng.
Lan TY, Chang WC, Lan TH, et al. Apolipoprotein E genotype and risk of developing physical limitations in elderly people. J Am Geriatr Soc. 2009 Jul;57(7):1308–9. doi: https://doi.org/10.1111/j.1532-5415.2009.02292.x. PubMed PMID: 19570164; PubMed Central PMCID: PMCPMC2705905. eng.
Rockwood K, Nassar B, Mitnitski A. Apolipoprotein E-polymorphism, frailty and mortality in older adults. J Cell Mol Med. 2008 Dec;12(6B):2754–61. doi: https://doi.org/10.1111/j.1582-4934.2008.00270.x. PubMed PMID: 18266965; PubMed Central PMCID: PMCPMC3828888.
Nadkarni NK, Perera S, Snitz BE, et al. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype. JAMA neurology. 2017;74(1):82–90. doi: https://doi.org/10.1001/jamaneurol.2016.3474. PubMed PMID: 27842173.
Del Campo N, Payoux P, Djilali A, et al. Relationship of regional brain beta-amyloid to gait speed. Neurology. 2016 Jan 5;86(1):36–43. doi: https://doi.org/10.1212/wnl.0000000000002235. PubMed PMID: 26643548; PubMed Central PMCID: PMCPMC4731288. eng.
Author information
Authors and Affiliations
Consortia
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Maltais, M., De Souto Barreto, P., Rolland, Y. et al. The Association of Apoe E4 Status with Lower Limb Function and Handgrip Strength in Older Adults. J Frailty Aging 8, 62–66 (2019). https://doi.org/10.14283/jfa.2019.7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14283/jfa.2019.7